677 related articles for article (PubMed ID: 1373963)
1. Prenatal biochemical screening for Down's syndrome and neural tube defects.
Wald NJ; Kennard A
Curr Opin Obstet Gynecol; 1992 Apr; 4(2):302-7. PubMed ID: 1373963
[TBL] [Abstract][Full Text] [Related]
2. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
3. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA
N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852
[TBL] [Abstract][Full Text] [Related]
4. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG
Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
[TBL] [Abstract][Full Text] [Related]
5. The role of maternal serum alpha-fetoprotein, human chorionic gonadotrophin and oestriol in the antenatal screening of Down's syndrome.
Chang TC; Cheng HH
Med J Malaysia; 1994 Dec; 49(4):351-4. PubMed ID: 7545778
[TBL] [Abstract][Full Text] [Related]
6. Down's syndrome: current screening techniques.
White RS
South Med J; 1989 Dec; 82(12):1483-6. PubMed ID: 2480649
[TBL] [Abstract][Full Text] [Related]
7. [Maternal serum screening for Down syndrome and neural tube defects].
van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH
Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776
[TBL] [Abstract][Full Text] [Related]
8. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Wald NJ; Watt HC
Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
[TBL] [Abstract][Full Text] [Related]
9. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
[TBL] [Abstract][Full Text] [Related]
10. [Noninvasive serum test for prenatal detection of Down syndrome, other chromosome abnormalities and open neural tube defects--a prospective study].
Zwahr C; Voss P; Kistner G
Geburtshilfe Frauenheilkd; 1994 Jun; 54(6):355-61. PubMed ID: 7522195
[TBL] [Abstract][Full Text] [Related]
11. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
Aitken DA; Crossley JA
Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
[TBL] [Abstract][Full Text] [Related]
12. Prenatal screening for open neural tube defects, Down's syndrome, and other major fetal disorders.
Haddow JE
Semin Perinatol; 1990 Dec; 14(6):488-503. PubMed ID: 1706536
[No Abstract] [Full Text] [Related]
13. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong.
Lam YH; Ghosh A; Tang MH; Tang LC; Lee CP; Sin SY; Ho PK
Prenat Diagn; 1998 Jun; 18(6):585-89. PubMed ID: 9664604
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
Hsu JJ; Hsieh TT; Soong YK; Spencer K
Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
[TBL] [Abstract][Full Text] [Related]
15. Screening and diagnosis of fetal neural tube defects, abdominal wall defects and Down's syndrome. With special reference to biochemical and ultrasound screening in the second trimester of pregnancy and to early amniocentesis.
Jørgensen FS
Dan Med Bull; 2001 Aug; 48(3):127-45. PubMed ID: 11556264
[No Abstract] [Full Text] [Related]
16. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum markers for Down's syndrome pregnancies.
Chew S; Anandakumar C; Ratnam SS
Singapore Med J; 1995 Aug; 36(4):417-23. PubMed ID: 8919160
[TBL] [Abstract][Full Text] [Related]
18. Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group.
Piggott M; Wilkinson P; Bennett J
J Med Screen; 1994 Jan; 1(1):45-9. PubMed ID: 8790485
[TBL] [Abstract][Full Text] [Related]
19. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ
N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909
[TBL] [Abstract][Full Text] [Related]
20. Prenatal screening for Down's syndrome with use of maternal serum markers.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
